Miniatura

Fitxers

17.Lopez-Varela E_Article_postprint.pdf (5.57 MB)
17.Lopez-Varela E_Suppl_postprint.pdf (1.26 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2022-02-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/205220

Treatment outcomes and safety in children with rifampicin-resistant TB

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.5588/ijtld.21.0476

Resum

BACKGROUND: The treatment of rifampicin-resistant TB (RR-TB) in children is evolving rapidly. As newer regimens are introduced into routine care, it is vital to compare their outcome and safety with well characterised clinical cohorts treated with historical regimens. METHODS: Study sample comprised a prospective observational cohort of children on routine RR-TB treatment, enrolled from 2011 to 2015 in Cape Town, South Africa. Children were followed for safety, treatment response and outcome. RESULTS: Of 136 children included, 27 (19.9%) were living with HIV and 48 (37.8%) had severe TB. The median time-to-culture conversion in children with bacteriological confirmation (n = 44) was 28.5 days (IQR 14.5-45). Overall, 118/129 (91.5%) had favourable TB treatment outcomes. Of 106 (77.9%) children who received an injectable drug, 9 (8.5%) developed hearing loss and 7/136 (5.1%) developed other Grade 3 or higher adverse events likely related to treatment. CONCLUSIONS: In this cohort with a substantial proportion of children with severe manifestations of TB and with HIV, TB treatment outcomes were excellent. Apart from hearing loss, few children developed severe adverse events related to treatment. This study provides robust reference data for future evaluation of shorter, injectable-sparing regimens.

Matèries

Tuberculosi, Efectes secundaris dels medicaments

Matèries (anglès)

Tuberculosis, Drug side effects

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

LÓPEZ VARELA, Elisa, GARCÍA PRATS, Anthony j., SEDDON, James a., DRAPER, Heather r., WINCKLER, Jana, LAAN, Louvina van der, PALMER, Megan, BURGER, W. andre, SCHAAF, H. simon, HESSELING, Anneke c.. Treatment outcomes and safety in children with rifampicin-resistant TB. _International Journal Of Tuberculosis And Lung Disease_. 2022. Vol. 26, núm. 2, pàgs. 133-141. [consulta: 25 de gener de 2026]. ISSN: 1815-7920. [Disponible a: https://hdl.handle.net/2445/205220]

Exportar metadades

JSON - METS

Compartir registre